Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP trial
NL-OMON58794Phase 4Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of clopidogrel in stroke and transient ischaemic attack (TIA) (2 arms), sponsored by Radboud University Medical Center. Started Dec 2024; status: recruiting.
02
Drugs
clopidogrel
03
Conditions
stroketransient ischaemic attack (TIA)
Beyond the preview
Go deeper on NL-OMON58794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58794.